PFIZER LEAK 2: Worries about falsifying data, and worries about FDA inspections in the covid 19 vaccine trials. Firing whistleblowers who report claims to the FDA. But….

 

PFIZER LEAK 2:

Worries about falsifying data, and worries about FDA inspections in the covid 19 vaccine trials.

Firing whistleblowers who report claims to the FDA.

But don’t worry the FDA ignored the report with allegations of falsifying data, not inputting adverse events, and unblinding the scientists.

The FDA decided to not inspect the site where concerns were raised.

Pfizer decided to not mention the issues in their approval application, and FDA decided to authorize within 1 day.

And the whistleblower was not the only one.

Multiple colleagues anonymously confirmed.

Multiple other researchers working on testing the Pfizer vaccine agreed with how sloppy it was.

They didn’t even have the resources to swab 477 people with suspected COVID.

https://www.bmj.com/content/375/bmj.n2635

Pfizer-funded vaccine talks spread fake news about competitors …

RT News:

Claims that rival vaccines could cause cancer and not be used for immunocompromised patients have been debunked by four doctors – including one who works on Pfizer’s advisory board. (National Post)

The allegations were made during talks delivered to the Canadian govt by the Pharma giant.

A list of disadvantages was apparently drawn from a scientific paper which the company knew about, says its author, but the company denies any editorial influence on the presentation or attempts to undermine competitors.

Pfizer hired a “reputable medical communication agency” to put the presentation together.

At arm’s length, or client-industry confidentiality?

Pfizer and Moderna mRNA COVID-19 vaccines; dramatically increase Acute Coronary Syndrome (ACS) risk

Acute coronary syndrome: Causes, symptoms, and treatment

Pfizer and Moderna mRNA COVID-19 vaccines “dramatically increase endothelial inflammatory markers and Acute Coronary Syndrome (ACS) risk” as measured by the PULS cardiac test, a study recently published in “Circulation,” the most prestigious cardiology journal, finds.

https://www.ahajournals.org/doi/10.1161/circ.144.suppl_1.10712